RE:RE:RE:RE:RE:RE:Just a warning.Rawrasaurus wrote:
Most of the people who still believe in the company left this site due to trolls. Mugs hasn't gone anywhere and we all talk every couple days on the other platform. Until things start going on the new trials, there's nothing to discuss. Feel free to keep bashing amongst yourselves though.
Exactly Raw !
As the bashers are too busy bashing - we've been doing risk assessments and getting questions answered - to understand what the value really is here.
Not sure why the ones who want to blame are also the ones who are interested so intimately in me - that makes no sense at all but neither does their logic and their understanding. Hahaha - love it !
At this point , we better understand why attacking acute
now makes sense and how it's one of those "kill 2 birds with one stone" type situations.
We better understand the multi-faceted liver issues at play.
We also see the risk profile for acute vs. chronic - and - the type of tools required in the toolbox in order to secure winning regimens. Not just related to OTENA but to all acute/chronic drugs in the pipeline.
IMO - everything is still in play.
There's always risk - but still in play.
That's what you get here - so don't expect any guarantees.
You want guarantees - put your money in a GIC. Hahaha !
: )